SpringWorks : FDA Grants Priority Review to NDA for Nirogacestat for Treatment of Adults with…
By Robb M. Stewart
SpringWorks Therapeutics Inc.'s new drug application for its investigational gamma secretase inhibitor for the treatment of adults with desmoid tumors has been accepted by the Food and Drug…